Stock Events

Stock Events

Kiromic BioPharma 

€5.19
0
+€0.00+0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
5.19
52W Low
5.19
Volume
-
Avg. Volume
0
Mkt Cap
7.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q4 2023
Q1 2026
Q2 2026
-13.53
-13.2
-12.87
-12.53
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-25.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5JU0.MU. It's not an investment recommendation.
Apple
3
AAPL
Microsoft
3
MSFT
AMD
3
AMD
Tesla
2
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics is involved in gene editing, a similar innovative technology space as Kiromic BioPharma's gene therapy approaches.
Editas Medicine
EDIT
Mkt Cap496.06M
Editas Medicine operates in the CRISPR gene editing sector, directly competing with Kiromic BioPharma's gene therapy and editing technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.79B
Intellia Therapeutics is a leading developer of CRISPR gene editing therapies, competing in the same innovative treatment space as Kiromic BioPharma.
Allogene Therapeutics
ALLO
Mkt Cap680.62M
Allogene Therapeutics is focused on allogeneic CAR T cell therapies, a direct competitor to Kiromic BioPharma's cell therapy approaches.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cell therapy space for cancer, similar to Kiromic BioPharma's focus.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.88B
BioMarin Pharmaceutical develops gene therapies for rare genetic diseases, indirectly competing with Kiromic BioPharma's gene therapy efforts.
Pfizer
PFE
Mkt Cap162.16B
Pfizer, with its investments in gene therapy and CRISPR technology, competes across a broad range of therapeutic areas including those targeted by Kiromic BioPharma.

About

KIROMIC BIOPHARMA INC
Show more...
CEO
Country
United States
ISIN
US4976342042
WKN
000A3D7BN

Listings

MU
DE
5JU.MU
OTC Link
US
KRBPQ
STU
DE
5JU.STU
MU
DE
5JU0.MU

0 Comments

Share your thoughts

FAQ

What is Kiromic BioPharma stock price today?▼
The current price of 5JU0.MU is €5.19 EUR — it has increased by +0% in the past 24 hours. Watch Kiromic BioPharma stock price performance more closely on the chart.
What is Kiromic BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Kiromic BioPharma stocks are traded under the ticker 5JU0.MU.
What is Kiromic BioPharma market cap?▼
Today Kiromic BioPharma has the market capitalization of 7.96M
What is Kiromic BioPharma revenue for the last year?▼
Kiromic BioPharma revenue for the last year amounts to 0 EUR.
What is Kiromic BioPharma net income for the last year?▼
5JU0.MU net income for the last year is -25.01M EUR.
In which sector is Kiromic BioPharma located?▼
Kiromic BioPharma operates in the Other sector.
When did Kiromic BioPharma complete a stock split?▼
The last stock split for Kiromic BioPharma was on March 13, 2023 with a ratio of 1:30.